Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 25,190 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PRE Clear all

Conditions: Adjustment Disorder, Anxiety Disorder, Depression, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Cancer
Interventions: Questionnaire Administration, Virtual Reality (VR) Intervention; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Staphylococcal Vaccine
Interventions: Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine, Placebo; Biological · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 3,450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 234
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 89 more

Conditions: Melanoma
Interventions: ZK-EPO; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: HIV Prevention, HIV Infection Primary
Interventions: RAMP-It-Up Initiation, Adherence, and Retention Intervention; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Atlanta, Georgia • Jackson, Mississippi • Providence, Rhode Island

Conditions: Multiple Myeloma
Interventions: bortezomib (Velcade), cyclophosphamide, G-CSF, Plerixafor; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 5
States / cities: Atlanta, Georgia • New York, New York

Conditions: Non-Small-Cell Lung Cancer
Interventions: XL999; Drug
Lead sponsor: Symphony Evolution, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 5
States / cities: Los Angeles, California • Atlanta, Georgia • Detroit, Michigan + 2 more

Conditions: Cirrhosis, Liver Failure
Interventions: Empagliflozin 10 MG, Matching Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Spinal Cord Injury
Interventions: Scheduled Telephone Intervention; Behavioral
Lead sponsor: Jeanne Hoffman; Other
Eligibility: 16 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Dysbiosis, Sarcopenia, Colon Cancer
Interventions: Standard Diet, BIG MACS Diet; Dietary Supplement
Lead sponsor: University of Minnesota; Other
Eligibility: 25 Years to 70 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Health Knowledge, Attitudes, Practice
Interventions: Digital Pediatric Bladder Health Patient Education Curriculum; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Myocarditis
Interventions: Not listed
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: Not listed
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Pembrolizumab, High-intensity focused ultrasound (HIFU); Drug · Device
Lead sponsor: Patrick Dillon, MD; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Influenza
Interventions: Influenza Donor Visit, Influenza Recipient Inpatient Exposures Sessions; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 49 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Cancer
Interventions: Not listed
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 21 Years to 99 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Buffalo, New York • Philadelphia, Pennsylvania

Conditions: Family Planning, Contraception, PostPartum
Interventions: LINCC intervention - enable co-schedule feature; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 2,518 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Wailuku, Hawaii • Chicago, Illinois • New York, New York

Conditions: Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs), Healthy Participants
Interventions: Treatment A, Treatment B, Treatment C, Treatment D, Acetaminophen; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Glioblastoma, Anaplastic Astrocytoma
Interventions: Fingolimod; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Focal Segmental Glomerulosclerosis, Minimal Change Disease, FSGS, MCD
Interventions: Biospecimen collection, Data collection; Other
Lead sponsor: University of Michigan; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Preeclampsia, Coagulation Disorder, Pregnancy Complications
Interventions: Thromboelastogram; Diagnostic Test
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Obese
Interventions: Standard PEEP (8 cmH₂O); Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Respiratory Insufficiency
Interventions: Vibrating Mesh Nebulizer Arm, Jet Nebulizer Arm; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 1 Year and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aortic Stenosis
Interventions: NT-pro-BNP levels; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: CIPN - Chemotherapy-Induced Peripheral Neuropathy
Interventions: Cryotherapy, Compression Therapy, Loose glove/sock; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Spinal Cord Injuries
Interventions: Mecamylamine Oral Tablet; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Detroit, Michigan

Search by objective public record fields.

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation

Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

Intervention to Enhance PrEP Persistence

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Empagliflozin in Patients With Cirrhosis and Ascites

Scheduled Telephone Intervention for Individuals With Spinal Cord Injury and Their Families

Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet

Impact, Feasibility, and Acceptability of Bladder Basics

A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

A Human Influenza Transmission Study Using Naturally Infected Community Donors

Cannabis Use and Outcomes in Black and White Patients With Cancer

Linking Inter-professional Newborn and Contraception Care

A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Thromboelastogram in Postdelivery Preeclamptic Patients

Mechanical Ventilation in Obese Surgical Patients

RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit

Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis

The CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL

Mecamylamine for Autonomic Dysreflexia Prophylaxis